RxDoctor Payments Data

Richard Bergenstal, MD

Endocrinology, Diabetes & Metabolism · St Louis Park, MNNPI 1669459061

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (44.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Abbott at 34.7% of the total. Among endocrinology, diabetes & metabolism clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$595,300in general payments, 2019–2025

Across 413 payments — averaging $1441.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$207K
  • Eli Lilly$80K
  • Novo Nordisk AS$78K
  • Dexcom, Inc.$51K
  • Roche Diabetes Care GmbH$45K
  • Sanofi$37K
  • plus $98K from 13 others
$3,489,121in research payments, 2019–2025

Across 338 payments — averaging $10,323 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$1.2M
  • Eli Lilly$1.1M
  • Medtronic$723K
  • Dexcom, Inc.$225K
  • Sanofi US Services Inc.$176K
  • Sanofi-aventis U.S. LLC$24K
  • plus $9K from 3 others

What the payments were for

  • Consulting fees$266,68945%
  • Speaking & faculty fees$209,57235%
  • Travel & lodging$103,66917%
  • Food & beverage$11,6942%
  • Education$1760%
  • Ownership interest$3,5001%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$595,300 in reported general payments places this provider in the 95th percentile of 120 endocrinology, diabetes & metabolism providers in Minnesota.

See all endocrinology, diabetes & metabolism providers in Minnesota

Medicare billing

Part B allowed, 2024
$88,588
Medicare patients
609
Services billed
1,675

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in St Louis Park

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →